In control studies, VAxC was similar to VACo2, obtained with the steady-state CO2 method (r = 0.87), while in critically ill patients the xenon measurement was significantly lower, averaging 54% of VAco2. In theory, underestimates in VAxC and decrease in the ratio VAX,/VAco2 relate to nonuniformity in regional ventilation and perfusion. The effect is greatest for the slightly soluble gas, xenon. The significant inverse correlation between .VAxe/ViAco2 and the physiologic shunt is consistent with this postulate.
A B S T R A C T A new triple tracer indicator dilution
technique has been used to measure alveolar ventilation as well as air and tissue volumes in the lungs of experimental animals and man. The tracers indocyanine green, [13I] antipyrine and xenon-133 were rapidly injected into the right atrium, while sampling was carried out from a peripheral artery.
Blood flow and tissue volumes were obtained by classical analysis of the indocyanine green and antipyrine concentration-time curves. A double exit-port, constant air flow model was used to analyze the xenon curves, because ventilatory loss led to incomplete recovery of the gas tracer in effluent blood. Uniform ventilation and perfusion were assumed. This analysis permitted calculation of alveolar ventilation (VAxe) and functional residual capacity (FRCxe) during normal breathing.
In control studies, VAxC was similar to VACo2, obtained with the steady-state CO2 method (r = 0.87), while in critically ill patients the xenon measurement was significantly lower, averaging 54% of VAco2. In theory, underestimates in VAxC and decrease in the ratio VAX,/VAco2 relate to nonuniformity in regional ventilation and perfusion. The effect is greatest for the slightly soluble gas, xenon. The significant inverse correlation between .VAxe/ViAco2 and the physiologic shunt is consistent with this postulate.
FRCxe was similar to the predicted FRC in animals but was 76% of the helium measured FRC in patients. FRCxe was significantly lower than the xenon measured air volumes during breath-holding when nonuniformity of ventilation was not operative. Lung tissue volumes in animals were 83%7o of gravimetric lung weights, while in patients the volumes were much lower than predicted. Nonhomogeneous lung function, including failure to perfuse the entire capillary bed, with resultantINTRODUCTION Alveolar ventilation and the functional residual capacity (FRC)1 are two indices of pulmonary function which have proven useful in the understanding and treating of abnormalities in respiratory gas exchange. The significance of these flows and volumes, lies both in their absolute values as well as in the uniformity of 1 Symbols used in this paper: C (amount/mil), concentration; f (breaths/min), respiratory frequency; FAg (ml gas/ml alveolar air), alveolar fraction of a gas, FRC (ml air), functional residual capacity during breathing; M (mass), amount of indicator injected; Q (ml/s), blood flow; R (dimensionless), fraction of injected tracer recovered in effluent blood; S, saturation of hemoglobin; t (s), time; I (s), transit time parameter, reduces to classic mean transit time when R = 1; 6TOT (s), total transit time from site of injection to site of sampling; at (s), difference in transits time parameters; T (s), time of one complete respiratory cycle; VA (ml air/s), alveolar ventilation -air flow through the control volume effective in tracer removal via the airway; VA (ml air), gas volume at end-expiration bounded by the "control surface", during breath-holding; VA (ml air), mean gas volume during breathing contained their distribution in the lungs. Thus, either absolute hypoventilation or severe non-uniformity in ventilation may result in abnormal blood gas tensions (1) . Decreases in the FRC have been associated with arterial hypoxemia. A normal chest X ray under these circumstances has led to the 'suggestion that right-to-left shunting is taking place through areas of microatelectasis (2) . The same association of hypoxemia and reduction in the FRC has been described in patients who develop stiff lungs following trauma or sepsis (3 (5, 6) . Application to the lung, or any organ, requires injection into the inflowing stream and blood sampling from the vascular outflow. It is usually assumed that a single exit-port is present and that all tracer eventually appears in the venous effluent.
The study of the ventilated lung with gas tracers requires special consideration. Under such circumstances two exit-ports exist. Tracer gas injected as a bolus into input blood may leave the lung through either of two parallel flow channels, blood vessels and airways. In theory, the fraction of gas tracer injected which is recovered in effluent blood is defined by solubility, blood flow, ventilation, and diffusional clearance. Measurement of the recovery fraction may in turn be used to determine these flows or clearances. The mean transit time of gas tracer particles recovered in effluent blood is defined by the ratio: volume of tracer distribution/sum of the parallel flows or clearances. Measurement of the mean transit time therefore provides sufficient additional information to measure the volume of gas tracer distribution.
THEORETICAL CONSIDERATIONS
The general lung model is shown in Fig. 1 . The control volume includes the perfused capillary bed which permits diffusion of blood-born tracers into the surrounding tissue Vt, and alveolar air spaces VA. Nonperfused regions (anatomic and physiologic dead space) lie outside the control volume and are excluded from this analysis. The model assumes that the ventilation/perfusion ratio is uniform throughout the lung. Time t = 0 occurs when the tracer crosses the control surface at point (i) (input) as Ci. Tracer leaves the control surface at (o) (output) as C.. The tissue and air space components are limited to those regions into which tracer can both penetrate and return to capillary blood to exit via port (o).
In the case of the inert gas xenon, we assume that there is no diffusion limitation between alveolar gas and blood (7) . Therefore the capillary blood (c) concentration at Tracer recovery must be complete.
THEORETICAL RESULTS
Breath-holding, R. = 1. General indicator dilution theory is directly applicable to this single exit-port model (5) . The air volume VA, is assumed constant, therefore the respiratory quotient is 1. Tracer gas is distributed according to its solubility coefficient X, in air, tissue, and blood. The volume equation 2 which relates the control volume to the product of blood clearance XgcQ, and mean transit time is VA + XgtVt + XgfCVC = XgcQig. (4) The blood volume V,, an element of the control volume, is defined by the reference tracer as Vc = 0ri (5) where r is the transit time through lung capillaries.
The general lung model ( Fig. 1 ) assumes that tracer injection and sampling are remote from the control surface. The absolute values of !g, tAp, or t, the mean transit times in the control volume, cannot be measured directly. This is so because the mean intravascular transit delays from injection site to (i) (i') and from (o) to the sampling site (t2) are unknown. Therefore, t = 0, when tracer enters the control surface is not defined. It may be stated that the total mean transit time of the reference indicator (r) from the site of injection to the site of sampling is trTOT = trl + ir + tr2- (6) Further, it is reasonable to assume that tgl = trl and ig2 = tr2y
It has been found that in the dog lung, the mean transit time of red cells is 0.3 s shorter than plasma (8) . Knowing that xenon is two times more soluble in red cells than plasma (9), the error incurred by assuming that the transit delays 1 and 2 are the same for xenon and indocyanine green, is 0.2 s. Since the average experimental Atier exceeds 20 s- (Tables 11, 111) there will be an underestimation of ZIX-Xe-r of approximately 1.0%o when (r) is indocyanine green.' Therefore Breath-holding and constant ventilation, R. < 1. Under most circumstances tracer gas recovery in effluent blood is < 1.
The remaining tracer may diffuse or be transported by venltilation. from the control volume through a second parallel flow channel, and exit the lung through a port other than (o).
Diffusion is defined as a flow or clearance, Z. It is the volume of air completely cleared of tracer per second and is assumed constant. This requires that there be a steady-state flux, without back diffusion, across a fixed barrier such as the pleural surface. 2 is determined by the diffusion constant and geometric parameters of the system, which include the area and thickness of the barrier. Ventilatory clearance VA, is assumed to be constant. This requires that there be continuous and uniform air flow through the control volume at a rate VA ml/s. Since the control volume contains no dead space, all air entering this region will be effective in tracer removal. The average size of the control volume will be VA Plus the tissue and blood components.
The total mass of gas tracer leaving the control volume will be the sum of tracer mass leaving from the two exit-ports, measured over the time period required for washout. Providing tracer is not entrapped within the control volume, the mass exiting will be equal to MIo, the mass injected. For the purposes of this discussion, Mg3 is defined by the units, milliliters of gas at 1 atm pressure and 370C. Cgco is milliliters of gas dissolved in 1 (25) where Aig-r is equivalent to the difference in transit times of gas and reference tracers from the site of injection to site of sampling (equation 12). Since Xxec = 0.18 (9), Rxe averages 0.23 (Table I I Five anesthetized dogs were given succinylcholine and their ventilation controlled. Indicator studies were done in rapid sequence during breath-holding at end-expiration and during breathing. The order of this sequence, breath-holding or breathing was varied.
Three in vitro studies were conducted in the left lower lobe of a dog at 370C, during breath-holding at end-expiration and during breathing. Recirculation was eliminated during indicator runs. Details of the perfusion apparatus have been described (11) .
Patients were selected for study, either because they were suffering acute arterial hypoxemia, or because their disease or the major surgical procedure indicated for its treatment, made the patient vulnerable to pulmonary complications (Table I) . Most patient studies were conducted during mechanical ventilatory assistance with an endotracheal tube in place. Control of the airway in the one patient without an endotracheal tube was accomplished with nose clips and a mouthpiece (ex. 14) .
Respiratory measurements. A 7 1 spirometer (Warren E. Collins, Inc., Braintree, Mass.) was used to measure tidal Volume VT, and respiratory frequency. The functional residual capacity FRCHC, was determined by helium dilution after switching the subject from the respirator to the Collins spirometer circuit. All patients demonstrated adequate ventilatory exchange during the several minutes required to reach helium equilibrium. Expired air was collected in small meteorologic balloons and analyzed for C02 tension with the Severinghaus electrode.
Hemodynamic measurements. All subjects had right atrial and either carotid or brachial arterial catheters. The brachial artery was utilized in patients. In addition, all patients had a balloon-tipped catheter (Swan-Garz, Edwards Laboratory, Santa Ana, Calif.) positioned in a distal pulmonary artery. On occasion this catheter was coupled to a strain gauge transducer to give pulmonary arterial and wedge pressures. Corp., Boston, Mass.) for both the extravascular tissue and air spaces. An isosmotic tracer mixture was prepared anerobically and a portion saved for analysis (12) . The mass of tracer injected was expressed as milligrams indocyanine green and CoUtnts per minute of 1311 and '33Xe. Patients were pretreated with 200 mg sodium iodide to block 13'l uptake by the thyroid. A rapid injection of 1-2 ml of tracer mix was made into the right atrial catheter, followed by a 5 ml flush of blood. Arterial sampling was started at the moment of injection, at a rate of 23 ml/min. In small monkeys, the rate was reduced to 11.6 ml/min. Mercury spacers were used to separate samples at 1-2-s intervals (12) . The concentration of indocyanine green (milligrams per milliliter) was measured spectrophotometri-Calculations. A typical set of indicator dilution curves is illustrated for experiment 16d (Fig. 2) . All tracer downslopes were monoexponential and were extrapolated by the method of least squares to ordinate values which were 1% of peak height. The integrals fo' C00(t)dt and Jo' tC,.(t)dt were calculated according to the method of Chinard et al. (6) . The mean transit time parameters tG, tAp, and tx0 were derived from equation 1 while blood flow Q was derived from equation 3. Tissue volume Vt is:
where AtAp-G (9) .
RESULTS
Alveolar ventilation was measured in all subjects: 2 rhesus monkeys, 11 mongrel dogs and 6 patients (Table II) . VAXe was calculated from equation 17 and VACO2 from equation 31. A comparison of these measurements is given in Fig. 3 . The six closed circles refer to dogs who had been subjected to hemorrhage while the 11 closed triangles refer to patients who were critically ill at the time of the study ( (Table II) . This was significantly lower than weights of the blood drained lungs, which averaged 10.7 ml/kg (P < 0.05). During hemorrhagic hypotension, the average of three runs was 5.70 ml/kg, while after the reinfusion of shed blood, the average was 12.9 ml/kg (n = 3). The results in these three groups demonstrate a wide scatter from the mean. The fractional recovery of antipyrine was 0.986±0.088 SD for all 28 runs. 6 The patients also showed wide variations in the measured tissue volume. The four patients (exps. [15] [16] [17] [18] who were seriously ill averaged 7.52 ml/kg±2.51 SD, or 274 ml/m2 (n = 11), while the two patients who made uneventful recoveries (exps. 14, 19), averaged 4 .70 ml/kg or 144 ml/m2 (n = 2). The fractional antipyrine recovery was 0.886±0.158 SD for all patient runs (n = 13).
Air volumes. FRCxe, measured by the tracer technique using equation 27, averaged 34.8 ml/kg ±i14.5 SD in the control dogs (n = 22), 23 .3 ml/kg in the two hypotensive animals (n = 3), and 15.3 ml/kg in the two animals who had their shed blood reinfused (n = 3) (Table II) In normal lungs, where there is minimal or no diffusion limitation across the pulmonary membrane, it is probable that tracer gases, including C02, diffuse beyond alveoli and enter the distal conducting airways (14) . Air exchange in these distal airways effectively removes tracer, and therefore, is included in the measured "alveolar ventilation". The rate of gas diffusion will determine the depth of tracer penetration into the conducting airways. As the rate of diffusion increases, there will be an apparent decrease in wasted, dead space ventilation and an increase in VA. Carbon dioxide is lighter than xenon-133 and therefore diffuses more rapidly in air.8 These considerations are consistent with the findings that VAxe < VAco2. Similar results have been reported using steady state techniques for the calculation of VAxe and VAco2 (10) . Although the findings are consistent with diffusion effects, it has been observed experimentally that during the period of a normal respiratory cycle, there is insufficient time for the diffusion separation of the gases krypton-85 and C02 (10) .
Another possible mechanism that may produce this disparity in VA, relates to regional variations in the ventilation-perfusion ratio. The ventilation equation 8 Graham's law states that the rate of diffusion is proportional to <density 17 assumes a single compartment lung with a uniform VA/Q ratio. Under such circumstances VAXe will be identical to VAco2. As the distribution of ventilationperfusion ratios around the average ratio becomes wider, tracer recovery in effluent blood will, in theory increase. This leads to a calculated VA which is lower than the single compartment lung (10) . A theoretical example of a two compartment lung is given in Fig. 4 .
Despite inhomogeneities, as long as the gas tracers have equal blood solubilities, there should be no disparity in their measured VA'S; although they will be lower than those measured in the homogeneous lung.
The critical issue involves the use of tracers of different solubilities in a lung with nonuniform ventilation perfusion ratios. In theory, this will lead to discrepancies in the calculated alveolar ventilation (15) . The lower the solubility, the lower the calculated VA. The experimental observation that VAXe < VAco2 is in keeping with the fact that CO2 is much more soluble in blood than xenon. The theoretical calculations illustrated in Fig. 4 shows that a 20% anatomic shunt will lead to reductions in VAXe to 42% of true ventilation while VAcO2 is minimally reduced to 97.3%. The striking reduction in VAXe relates to the low solubility of xenon. Only 15% of xenon entering the lung via input blood is recovered in the venous effluent. A 20%7 anatomic shunt results in 30% recovery. In the case of the highly soluble gas C02, 90.00%o is normally recovered, (VA/0 = 1, X = 9) whereas a 20%o shunt leads to a minimal increase in recovery to 90.24%o. Thus, although the absolute mass of xenon cleared by ventilation may be far greater than C02, the reduction in the efficiency of this ventilatory clearance is much more marked for xenon in the presence of shunting. The reduced efficiency of gas exchange due to VA/Q inhomogeneities may be described by the ratio VAxe/VAco2. Nonuniformity in perfusion also results in VA/Q imbalance and again leads to greater underestimates in VAXe than VAcO2 (Fig. 5) . When regional perfusion is completely interrupted, that region is no longer included within the control volume. Ventilation to the region (dead space ventilation) is then unmeasured regardless of the tracer used.
These theoretical considerations demonstrate that although VA is unchanged, the effective ventilation depends on both gas solubility and the degree of non- Xenon is a poorly soluble gas and Rxe is normally about 0.15. As VA1 and therefore VA1/91 decrease to zero, Rxe will increase substantially. Since VA, Q, and X are constant VAxe will decrease dramatically (solid line). The greatest rate of increase in Rxe (and therefore decrease in VAxe) will be when the VA/Q ratios deviate about a mean VA/Q = XXe = 0.181 (9) . In the case of the very soluble gas C02 where X -9 (10), recovery is usually very high (,-0.90). Therefore VACO2 is relatively unaffected by low VA/Q ratios. The minimal fall in VAcO2 leads to use of the ratio VAxe/VAco2 as an index of nonuniformities in regional VA/Q.
ever, that the data points fall to the right of the theoretical curve (Fig. 6 ). Agreement is somewhat better when Qs/Q is calculated during 50% oxygen breathing. The two-compartment lung described in Fig. 4 (21) .
The data in patients is also consistent with this perfusion hypothesis. In the two patients who made uneventful recoveries, Vt was found to be 144 nil/M2, while in five comparable individuals, the tritiated water space after correction for water in blood was 112 ml/m2 (20) . The predicted normal parenchymal volume is 259 ml/M2 (22) . The group of patients who were critically ill had an enlarged Vt of 274 ml/m2. Without knowledge of the size of the perfusion bed, a precise estimate of iung weight cannot be given.
Air volumes. In control dogs, FRCxe was found to be 34.8 ml/kg while the predicted FRC is 33.1 ml/kg (23, 24) . In the complete patient series, FRCxe was significantly lower than the helium measured FRC, averaging 76.5% (P < 0.05). Several factors may be responsible for this discrepancy in FRCXe and FRCHC.
These are: (1) regional variations in the VA/Q ratio, (2) restriction in the volume available to xenon because of (a) diffusion limitations and (b) contraction of the perfusion bed.
Nonhomogeneous lung function. Since both the ventilation and volume equations (17 and 27) assume a single compartment lung, it might be argued that VA/Q variations will lead to underestimates in both VAxe and FRCx,. The simulated two-compartment lung model shows that this is not necessarily true VAxe/VAco2 to decrease. This is shown by the simulated two compartment lung model (see Fig. 4 ). In this case VA1 = 0 while Qi was increased from 0 to 30% of total flow (solid line).
The data from Table II XVhen regional flow ceases, neither ventilation nor volume will be measured. FRCije is unaffected. Therefore, while the ventilation ratio remains constant, the volume ratio falls. These three common examples of ventilation-perfusion inhomogeneity, bronchial obstruction, atelectasis, and physiologic dead space, lead to different effects on the VAxe/VAco2 and FRCxe/FRCHe ratios. Since these pathologic events often occur together, and in varying degree, it is not surprising that there is no significant correlation between the volume ratio and either Qs/Q or the ventilation ratio (Table II) .
Comparison of air volumes measured during breathing and breath-holding demonstrate that FRCXe was consistently lower than VAxe, averaging 87.6% (Table III) . During breath-holding, VAxe should be virtually insensitive to inhomogeneities in the distribution of volume and of course ventilation. This is true, particularly as xenon recovery approaches unity. Under these circumstances, the volume measured is simply the sum of the regional volumes (equation 4). In theory therefore, the ratio FRCXe/VAXe should reflect the nonhomogeneous VA/Q distributions present during the breathing phase of these experiments (Os/l = 0.25).
Experimental data in Fig. 5 (Table II) Table III , occurred through lung regions containing entrapped air. Diffusion. In addition to nonhomogeneities in lung function, diffusion may be a factor in the underestimation of FRCXe. In theory, volumes measured by indicator techniques are those into which tracer has penetrated before returning to exit the lung via effluent blood. Since the air spaces are large, and many of them are distant from the perfusion bed, the short time available for diffusion interchange during breathing will limit the volumes measured. During breath-holding, there is sufficient time for xenon to evolve into airways distant to alveolae. In one second, xenon diffuses approximately 1.4 cm in air.10 Therefore over the 1-3 min period required for washout of xenon from the breath-holding lung, it is probable that diffusion interchange occurs with the entire FRC. These differences in the volume accessible to xenon during breathing and breath-holding may in part account for the finding, FRCxe < VAXe. Membrane diffusion limitations will accentuate the underestimate in FRCXe. The relative importance of this membrane phenomenon in sick patients is uncertain.
During breathing, there is no direct data to resolve the question as to how much airway volume is contained within the control volume. In theory, during one normal respiratory cycle there are no oxygen concentration gradients from respiratory bronchiles to alveoli (14) . Therefore significant, particularly in sick patients, and limit the independent use of indicator methods. 10 Based on the relationship (X2)* = Vt, where (X2)* is the root mean square diffusional displacement. D is the diffusion coefficient and t is time in seconds (6) .
Combination of tracer techniques with other measurements may circumvent these problems. Thus, if it can be shown that the VAXe/VACO2 ratio is unity, FRCxe will be a precise estimate of the volume of air surrounding the perfusion bed. This bed can also be described by the ratio FRCxe/Vt (Table II) . In addition, FRCxe/FRCHe will provide an estimate of the size of the perfusion bed, and when divided into Vt will yield total tissue volume.
The errors inherent in these indicator methods can be used to advantage to provide information concerning nonhomogeneity. The simultaneous use of gases of different solubilities may permit understanding of the type and degree of maldistributions of volume and ventilation which occur in pulmonary disease (15) (16) (17) . Interpretation of such data can offer insights into pathophysiologic mechanisms. The ability to distinguish flow through nonventilated but air-containing regions, from flow through regions of alveolar collapse may serve to identify airway obstructions or alveolar instability as a cause of right-to-left shunting.
